Calmodulin mutations and life-threatening cardiac arrhythmias: insights from the International Calmodulinopathy RegistryLia Crotti, Peter J. Schwartz, Susan P. Etheridge et al.|European Heart Journal|2019Cited by 184
Effects of a 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor, Fluvastatin, on Coronary Spasm After Withdrawal of Calcium-Channel BlockersHirofumi Yasue, Yoshihiko Saito, Yuji Mizuno et al.|Journal of the American College of Cardiology|2008Cited by 177
Late Adverse Events After Implantation of Sirolimus-Eluting Stent and Bare-Metal StentMasahiro Natsuaki, Takeshi Kimura, Takeshi Morimoto et al.|Circulation Cardiovascular Interventions|2014Cited by 77
Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary InterventionKoji Goto, Takeshi Kimura, Kentaro Nakai et al.|The American Journal of Cardiology|2014Cited by 56
Comparison of Long-Term Outcome After Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Unprotected Left Main Coronary Artery Disease (from the CREDO-Kyoto PCI/CABG Registry Cohort-2)Hiroki Shiomi, Takeshi Kimura, Takeshi Morimoto et al.|The American Journal of Cardiology|2012Cited by 41